REVISED LABELING FOR TDX BENZODIAZEPINES— 510(k) K874489

Name: FDA 510(k) clearance K874489
Creator: U.S. Food and Drug Administration
Published: 1987-11-23

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K874489 for REVISED LABELING FOR TDX BENZODIAZEPINES, Substantially Equivalent on 1987-11-23. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code JXM
Device class: Class 2
Regulation: 21 CFR 862.3170
Advisory panel: Clinical Toxicology
Date received: 1987-10-30
Decision date: 1987-11-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JXM

view all

K243498 — Alinity c Benzodiazepines Reagent Kit2024-12-11
K221765 — ONLINE DAT Benzodiazepines II2022-12-23
K190968 — CEDIA Benzodiazepine Assay2019-12-09
K173963 — DRI Benzodiazepine Assay2018-02-21
K163590 — Psychemedics Microplate EIA for Benzodiazepines in Hair2017-09-15

More clearances from Abbott Laboratories

view all

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.